Mario Gabelli Vericel Corp Call Options Transaction History
Gamco Investors, Inc. Et Al
- $8.56 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VCEL
# of Institutions
270Shares Held
49.1MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$361 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$198 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$154 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$111 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$92.9 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.11B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...